Emerald Joint Venture Receives Licenses from Health Canada to Sell Proprietary Products Supporting the Endocannabinoid System

Endo Brain recently awarded 2018 SupplySide Editor’s Choice Award for Brain Health

Planned mid-2019 product launch will open natural health product, grocery, and pharmacy store channels to Emerald non-cannabis product line

VICTORIA, British Columbia, Dec. 04, 2018 (GLOBE NEWSWIRE) — Emerald Health Therapeutics Inc. (“Emerald” or “the Company”) (TSXV: EMH; OTCQX: EMHTF) today announced that its joint venture, Emerald Health Naturals (“EHN”), has received product licenses and natural product numbers (NPNs) from Health Canada to sell its award-winning Endo product line of endocannabinoid-supporting nutritional products in Canada. The Endo product line has been designed to impact stress, anxiety, restless sleep, pain and other conditions using non-cannabis ingredients. EHN intends to launch the Endo product line over-the-counter in Canadian natural health product, grocery, and pharmacy stores by mid-2019.

“Our Endo product line was developed by internationally recognized natural health product experts and is unique in the natural healthcare

... read more at: https://globenewswire.com/news-release/2018/12/04/1661525/0/en/Emerald-Joint-Venture-Receives-Licenses-from-Health-Canada-to-Sell-Proprietary-Products-Supporting-the-Endocannabinoid-System.html